Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.08 trillion and total revenue of $110 billion.
Market Cap
1.08T
Revenue
110B
Profits
-41.26B
PE Ratio
n/a
Profit Margin
-37.51%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.72B | 0.76% | 1,572,467 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.97B | 2.66% | 984,965 | 14.92B |
| 3 | ARGX | argenx SE | 50.20B | 1.37% | 314,187 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.06B | 2.26% | 987,477 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 33.16B | 3.09% | 2,004,441 | - |
| 6 | RPRX | Royalty Pharma plc | 31.65B | 1.78% | 4,462,515 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.02B | 1.57% | 206,640 | 5.70B |
| 8 | INSM | Insmed Incorporated | 22.51B | 0.13% | 2,975,412 | 819.56M |
| 9 | BNTX | BioNTech SE | 22.37B | -0.77% | 659,703 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.64B | 1.59% | 3,612,149 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.57B | 6.22% | 2,268,511 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 19.47B | 7.49% | 6,905,489 | 2.23B |
| 13 | GMAB | Genmab A/S | 14.53B | 0.13% | 1,376,889 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.49B | 2.13% | 910,224 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 13.47B | 0.09% | 379,385 | 998.25M |
| 16 | EXEL | Exelixis, Inc. | 12.97B | 6.30% | 2,977,963 | 2.38B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.82B | 2.50% | 2,740,908 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.20B | 1.16% | 1,303,152 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.02B | 5.10% | 781,739 | 708.24M |
| 20 | SMMT | Summit Therapeutics Inc. | 11.70B | 1.41% | 3,835,518 | - |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.25B | 7.79% | 264,446 | 1.13B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.56B | 2.51% | 2,266,873 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.22B | 2.44% | 1,484,143 | 622.01M |
| 24 | CYTK | Cytokinetics, Incorporated | 9.60B | -0.28% | 1,594,303 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 8.90B | 2.94% | 240,361 | 417.30M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 8.28B | 5.34% | 2,144,430 | 1.51B |
| 27 | TECH | Bio-Techne Corporation | 7.96B | 2.17% | 2,222,272 | 1.21B |
| 28 | CORT | Corcept Therapeutics Incorporated | 7.80B | 2.04% | 788,819 | 769.10M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 7.78B | 8.08% | 676,327 | 7.46M |
| 30 | IBRX | ImmunityBio, Inc. | 7.52B | -0.69% | 8,930,232 | 140.98M |
| 31 | NUVL | Nuvalent, Inc. | 7.12B | -1.28% | 1,475,441 | - |
| 32 | PCVX | Vaxcyte, Inc. | 6.78B | -1.01% | 1,508,210 | - |
| 33 | LEGN | Legend Biotech Corporation | 6.68B | -0.83% | 3,859,091 | 1.14B |
| 34 | ABVX | ABIVAX Société Anonyme | 6.59B | 24.34% | 7,153,365 | 5.67M |
| 35 | IMVT | Immunovant, Inc. | 6.40B | 0.74% | 1,861,076 | - |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.38B | 6.30% | 1,720,072 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.31B | 6.96% | 1,126,234 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.17B | -0.13% | 840,514 | 15.00M |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 6.14B | 2.34% | 417,150 | 74.06M |
| 40 | KYMR | Kymera Therapeutics, Inc. | 6.02B | 2.69% | 859,442 | 51.48M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.81B | 0.43% | 336,338 | 217.17M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.70B | 0.66% | 1,124,822 | 827.11M |
| 43 | TGTX | TG Therapeutics, Inc. | 5.68B | 9.47% | 3,086,649 | 700.35M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.61B | -0.24% | 619,604 | 569.61M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.51B | -1.53% | 2,471,509 | - |
| 46 | BLTE | Belite Bio, Inc | 5.40B | 1.70% | 165,830 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.35B | -0.09% | 1,122,755 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.17B | 2.18% | 1,706,334 | 7.50M |
| 49 | CRSP | CRISPR Therapeutics AG | 5.02B | 0.12% | 1,270,381 | 4.10M |
| 50 | CGON | CG Oncology, Inc. | 4.80B | -2.00% | 964,829 | 5.07M |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 4.70B | 0.77% | 157,007 | 274.48M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.64B | 4.17% | 580,462 | 1.34M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.38B | -6.30% | 2,642,853 | 907.29M |
| 54 | CELC | Celcuity Inc. | 4.34B | -2.70% | 5,272,939 | - |
| 55 | ERAS | Erasca, Inc. | 4.10B | -2.23% | 4,617,186 | - |
| 56 | MANE | Veradermics, Incorporated | 4.04B | -1.47% | 579,012 | - |
| 57 | TVTX | Travere Therapeutics, Inc. | 3.99B | 5.21% | 1,769,272 | 536.20M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 3.90B | -2.79% | 1,444,139 | - |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.03% | 1,682,037 | 596.96M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.75B | 1.26% | 1,698,464 | 22.57M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.67B | 2.58% | 814,349 | 1.10B |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.49B | 1.47% | 857,809 | 18.07M |
| 63 | ORKA | Oruka Therapeutics, Inc. | 3.45B | 3.57% | 829,892 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.41B | 0.14% | 1,459,828 | - |
| 65 | RLAY | Relay Therapeutics, Inc. | 3.33B | -2.55% | 3,723,404 | 10.68M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.12B | 1.60% | 1,025,138 | - |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.11B | -0.14% | 1,326,261 | 56.99M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.00B | -2.49% | 956,218 | 236.00M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.97B | 4.35% | 1,556,601 | - |
| 70 | TLX | Telix Pharmaceuticals Limited | 2.96B | -4.26% | 251,284 | 803.79M |
| 71 | BEAM | Beam Therapeutics Inc. | 2.94B | 2.04% | 914,666 | 164.01M |
| 72 | KLRA | Kailera Therapeutics, Inc. | 2.90B | -0.93% | 422,318 | - |
| 73 | IRON | Disc Medicine, Inc. | 2.69B | 3.46% | 333,608 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.67B | 2.69% | 1,035,584 | 415.62M |
| 75 | GPCR | Structure Therapeutics Inc. | 2.67B | 0.83% | 473,039 | - |
| 76 | DFTX | Definium Therapeutics, Inc. | 2.57B | 3.19% | 2,290,018 | - |
| 77 | ALMS | Alumis Inc. | 2.56B | 0.20% | 1,153,605 | 8.40M |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.53B | 2.25% | 461,522 | 535.08M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.50B | 1.90% | 1,067,242 | 225.27M |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.34B | 3.01% | 875,859 | 865.00K |
| 81 | VERA | Vera Therapeutics, Inc. | 2.24B | 0.03% | 989,794 | - |
| 82 | IMNM | Immunome, Inc. | 2.24B | 2.43% | 1,245,959 | 4.02M |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | 2.89% | 1,471,047 | 670.00M |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.19B | 1.44% | 695,923 | - |
| 85 | KOD | Kodiak Sciences Inc. | 2.11B | 1.97% | 928,316 | - |
| 86 | PHVS | Pharvaris N.V. | 2.10B | 4.00% | 703,635 | - |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | -13.14% | 8,177,138 | - |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 1.82% | 1,496,611 | 298.30M |
| 89 | NKTR | Nektar Therapeutics | 2.00B | 1.14% | 920,390 | 55.63M |
| 90 | ZLAB | Zai Lab Limited | 1.93B | 0.12% | 584,341 | 453.28M |
| 91 | TRVI | Trevi Therapeutics, Inc. | 1.91B | -0.37% | 720,082 | - |
| 92 | QURE | uniQure N.V. | 1.88B | 11.66% | 2,932,311 | 18.09M |
| 93 | MESO | Mesoblast Limited | 1.87B | - | 108,606 | 65.38M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | 3.74% | 1,008,646 | 899.11M |
| 95 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -3.88% | 18,389,137 | 66.41M |
| 96 | STOK | Stoke Therapeutics, Inc. | 1.83B | 2.72% | 449,722 | 32.08M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 0.48% | 2,044,145 | 52.04M |
| 98 | NTLA | Intellia Therapeutics, Inc. | 1.82B | -0.84% | 2,652,564 | 66.09M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.81B | 3.02% | 1,685,016 | 70.92M |
| 100 | ADMA | ADMA Biologics, Inc. | 1.80B | 2.11% | 2,919,139 | 509.86M |
| 101 | LKFT | Lakefront Biotherapeutics NV | 1.79B | 0.75% | 404,597 | 1.20B |
| 102 | ZYME | Zymeworks Inc. | 1.78B | 1.00% | 526,822 | 81.26M |
| 103 | NBTX | Nanobiotix S.A. | 1.77B | -4.60% | 49,183 | 38.27M |
| 104 | VCEL | Vericel Corporation | 1.77B | 0.84% | 599,416 | 292.09M |
| 105 | RAPP | Rapport Therapeutics, Inc. | 1.77B | 6.02% | 198,496 | 20.00M |
| 106 | ABCL | AbCellera Biologics Inc. | 1.75B | -6.69% | 6,982,817 | 79.21M |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 1.71B | -0.06% | 1,928,876 | 2.18B |
| 108 | TYRA | Tyra Biosciences, Inc. | 1.71B | 0.10% | 769,598 | - |
| 109 | IOVA | Iovance Biotherapeutics, Inc. | 1.69B | -7.56% | 8,231,002 | 285.61M |
| 110 | NVAX | Novavax, Inc. | 1.68B | -0.10% | 3,082,973 | 596.34M |
| 111 | GHRS | GH Research PLC | 1.68B | -1.77% | 140,947 | - |
| 112 | AAPG | Ascentage Pharma Group International | 1.66B | -3.14% | 22,131 | 82.08M |
| 113 | ATAI | AtaiBeckley Inc. | 1.66B | -5.82% | 4,824,013 | 3.49M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.66B | 0.60% | 319,272 | - |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.66B | 10.34% | 571,062 | - |
| 116 | GENB | Generate Biomedicines, Inc. | 1.65B | 7.85% | 753,852 | 30.30M |
| 117 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 4.41% | 679,110 | 66.05M |
| 118 | NUVB | Nuvation Bio Inc. | 1.64B | -3.67% | 3,225,544 | 143.05M |
| 119 | BHVN | Biohaven Ltd. | 1.63B | 6.71% | 2,842,332 | - |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | -0.27% | 1,248,662 | 217.17M |
| 121 | INVA | Innoviva, Inc. | 1.60B | 1.64% | 909,630 | 420.69M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -5.44% | 1,325,609 | 71.78M |
| 123 | CAPR | Capricor Therapeutics, Inc. | 1.60B | 1.10% | 535,774 | 11.13M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | -2.46% | 1,302,598 | 7.47M |
| 125 | SLS | SELLAS Life Sciences Group, Inc. | 1.52B | -1.68% | 7,465,190 | - |
| 126 | ANAB | AnaptysBio, Inc. | 1.49B | -0.04% | 720,332 | 232.39M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.49B | -0.85% | 881,789 | 42.95M |
| 128 | VIR | Vir Biotechnology, Inc. | 1.48B | 0.34% | 2,373,264 | 65.50M |
| 129 | FTRE | Fortrea Holdings Inc. | 1.48B | 1.76% | 1,021,507 | 2.71B |
| 130 | IMCR | Immunocore Holdings plc | 1.46B | -3.11% | 647,831 | 412.81M |
| 131 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.04% | 6,240,034 | 114.48M |
| 132 | MBX | MBX Biosciences, Inc. | 1.43B | -2.12% | 466,094 | - |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 1.70% | 327,721 | 1.30M |
| 134 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -0.47% | 712,108 | - |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.38B | -2.40% | 318,621 | - |
| 136 | SEPN | Septerna, Inc. | 1.38B | 2.30% | 286,521 | 72.26M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.38B | 2.35% | 412,438 | 20.00M |
| 138 | IMTX | Immatics N.V. | 1.37B | 1.64% | 546,590 | 43.00M |
| 139 | PGEN | Precigen, Inc. | 1.36B | -1.30% | 7,785,116 | 31.60M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.34B | 2.24% | 477,330 | - |
| 141 | ARDX | Ardelyx, Inc. | 1.34B | -1.81% | 3,816,699 | 427.68M |
| 142 | SVRA | Savara Inc. | 1.33B | - | 1,806,058 | - |
| 143 | BCAX | Bicara Therapeutics Inc. | 1.31B | 1.83% | 548,306 | - |
| 144 | URGN | UroGen Pharma Ltd. | 1.30B | 0.23% | 358,938 | 140.49M |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.29B | 3.66% | 193,138 | - |
| 146 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.25B | 0.21% | 4,619,675 | 204.73M |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.16B | -4.73% | 210,966 | - |
| 148 | AVLN | Avalyn Pharma Inc. | 1.12B | 3.73% | 206,224 | - |
| 149 | WVE | Wave Life Sciences Ltd. | 1.11B | 1.23% | 2,925,021 | 71.80M |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.10B | 1.58% | 415,688 | 10.00M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.07B | -4.24% | 268,661 | 8.28M |
| 152 | DBVT | DBV Technologies S.A. | 1.04B | -2.91% | 162,454 | 5.74M |
| 153 | MNKD | MannKind Corporation | 1.04B | -2.04% | 3,493,150 | 360.78M |
| 154 | EYPT | EyePoint, Inc. | 1.03B | -1.52% | 835,498 | 7.61M |
| 155 | CRVS | Corvus Pharmaceuticals, Inc. | 975.45M | -0.77% | 1,601,433 | - |
| 156 | DRTS | Alpha Tau Medical Ltd. | 954.06M | 18.48% | 3,132,096 | - |
| 157 | CGEM | Cullinan Therapeutics, Inc. | 934.16M | -0.91% | 908,548 | - |
| 158 | ABSI | Absci Corporation | 926.08M | -6.46% | 5,110,065 | 1.84M |
| 159 | SPTX | Seaport Therapeutics, Inc. | 921.89M | 1.02% | 91,130 | - |
| 160 | OLMA | Olema Pharmaceuticals, Inc. | 918.02M | -1.68% | 1,413,422 | - |
| 161 | ANNX | Annexon, Inc. | 883.11M | 2.47% | 2,919,018 | - |
| 162 | MGTX | MeiraGTx Holdings plc | 869.60M | 1.62% | 492,656 | 79.76M |
| 163 | SPRY | ARS Pharmaceuticals, Inc. | 868.90M | -1.69% | 1,208,915 | 98.99M |
| 164 | SANA | Sana Biotechnology, Inc. | 868.27M | -3.70% | 2,231,147 | - |
| 165 | JBIO | Jade Biosciences, Inc. | 868.24M | -0.90% | 469,628 | - |
| 166 | PHAR | Pharming Group N.V. | 866.52M | 0.90% | 4,427 | 369.49M |
| 167 | ABUS | Arbutus Biopharma Corporation | 859.29M | 2.11% | 1,728,756 | 191.45M |
| 168 | XNCR | Xencor, Inc. | 846.70M | 1.87% | 602,542 | 97.36M |
| 169 | JANX | Janux Therapeutics, Inc. | 828.78M | -1.38% | 688,508 | 13.73M |
| 170 | REPL | Replimune Group, Inc. | 824.07M | 12.51% | 8,983,651 | - |
| 171 | LXRX | Lexicon Pharmaceuticals, Inc. | 821.76M | -2.12% | 2,650,074 | 69.64M |
| 172 | TBPH | Theravance Biopharma, Inc. | 820.21M | 2.12% | 334,985 | 109.78M |
| 173 | IVA | Inventiva S.A. | 817.33M | -1.22% | 1,251,026 | 7.94M |
| 174 | ORIC | ORIC Pharmaceuticals, Inc. | 811.58M | 2.89% | 2,280,577 | - |
| 175 | LBRX | LB Pharmaceuticals Inc | 801.51M | 3.44% | 198,406 | - |
| 176 | PHAT | Phathom Pharmaceuticals, Inc. | 801.45M | 4.56% | 2,037,312 | 204.89M |
| 177 | OCS | Oculis Holding AG | 793.50M | 6.92% | 1,675,013 | 1.40M |
| 178 | ODTX | Odyssey Therapeutics, Inc. | 787.34M | -1.42% | 341,573 | 2.98M |
| 179 | KURA | Kura Oncology, Inc. | 768.34M | -3.51% | 1,587,545 | 71.64M |
| 180 | AURA | Aura Biosciences, Inc. | 758.86M | -0.29% | 253,012 | - |
| 181 | DRUG | Bright Minds Biosciences Inc. | 757.92M | -3.07% | 761,390 | - |
| 182 | GERN | Geron Corporation | 744.16M | -0.85% | 10,086,891 | 196.12M |
| 183 | OMER | Omeros Corporation | 735.33M | -0.97% | 1,848,198 | 9.89M |
| 184 | VOR | Vor Biopharma Inc. | 728.26M | -1.61% | 655,238 | - |
| 185 | AVTX | Avalo Therapeutics, Inc. | 722.25M | -1.58% | 2,515,360 | 59.00K |
| 186 | EVMN | Evommune, Inc. | 710.64M | -0.45% | 271,971 | 10.00M |
| 187 | CTMX | CytomX Therapeutics, Inc. | 701.00M | 1.90% | 3,259,752 | 35.54M |
| 188 | ALLO | Allogene Therapeutics, Inc. | 690.31M | -2.44% | 9,053,879 | 22.00K |
| 189 | SLDB | Solid Biosciences Inc. | 674.38M | 4.10% | 918,233 | - |
| 190 | RLMD | Relmada Therapeutics, Inc. | 663.96M | -1.40% | 797,606 | - |
| 191 | ANRO | Alto Neuroscience, Inc. | 660.74M | 0.75% | 471,500 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 652.05M | 2.65% | 632,772 | - |
| 193 | ZVRA | Zevra Therapeutics, Inc. | 647.90M | 0.74% | 1,577,824 | 122.29M |
| 194 | CRMD | CorMedix Inc. | 645.66M | 0.73% | 835,619 | 400.05M |
| 195 | CADL | Candel Therapeutics, Inc. | 644.78M | 4.51% | 1,959,184 | - |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 643.26M | -2.90% | 174,616 | - |
| 197 | TENX | Tenax Therapeutics, Inc. | 634.12M | -1.64% | 532,585 | - |
| 198 | SGP | SpyGlass Pharma, Inc. | 627.08M | 2.18% | 47,138 | - |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 617.31M | -4.54% | 1,578,402 | 8.37M |
| 200 | CBIO | Crescent Biopharma, Inc. | 597.46M | 5.73% | 146,804 | 11.88M |
| 201 | AGMB | AgomAb Therapeutics NV | 590.98M | 1.69% | 88,208 | - |
| 202 | IMMX | Immix Biopharma, Inc. | 589.03M | 0.90% | 1,051,687 | - |
| 203 | CABA | Cabaletta Bio, Inc. | 583.74M | -2.72% | 4,454,364 | - |
| 204 | DNA | Ginkgo Bioworks Holdings, Inc. | 570.28M | -6.43% | 1,340,004 | 151.40M |
| 205 | PRME | Prime Medicine, Inc. | 567.14M | -2.18% | 3,043,292 | 4.03M |
| 206 | RIGL | Rigel Pharmaceuticals, Inc. | 560.61M | 0.93% | 422,195 | 299.77M |
| 207 | ALT | Altimmune, Inc. | 558.14M | -1.03% | 3,010,921 | 36.00K |
| 208 | TECX | Tectonic Therapeutic, Inc. | 539.66M | 4.27% | 130,953 | - |
| 209 | MDXG | MiMedx Group, Inc. | 537.69M | 1.12% | 1,297,456 | 389.42M |
| 210 | TRAX | First Tracks Biotherapeutics, Inc. | 534.55M | -5.08% | 524,392 | - |
| 211 | VALN | Valneva SE | 523.48M | -0.89% | 15,323 | 180.25M |
| 212 | XOMA | XOMA Royalty Corporation | 522.96M | 0.02% | 67,789 | 48.56M |
| 213 | PROK | ProKidney Corp. | 522.56M | -8.95% | 835,790 | 889.00K |
| 214 | GYRE | Gyre Therapeutics, Inc. | 521.73M | 2.70% | 72,128 | 117.05M |
| 215 | EIKN | Eikon Therapeutics, Inc. | 510.53M | -1.77% | 353,792 | - |
| 216 | ACHV | Achieve Life Sciences, Inc. | 505.08M | -2.19% | 1,359,821 | - |
| 217 | CLYM | Climb Bio, Inc. | 498.70M | -6.79% | 1,103,503 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 498.19M | 2.80% | 948,557 | 88.24M |
| 219 | ARVN | Arvinas, Inc. | 496.81M | -3.75% | 1,270,101 | 89.40M |
| 220 | ASMB | Assembly Biosciences, Inc. | 486.91M | 0.33% | 180,834 | 71.10M |
| 221 | RZLT | Rezolute, Inc. | 478.46M | 14.50% | 5,231,805 | - |
| 222 | KYTX | Kyverna Therapeutics, Inc. | 473.35M | -1.01% | 816,254 | - |
| 223 | CTNM | Contineum Therapeutics, Inc. | 467.89M | 1.09% | 434,324 | - |
| 224 | PRTA | Prothena Corporation plc | 466.99M | -2.94% | 592,877 | 57.94M |
| 225 | ANL | Adlai Nortye Ltd. | 450.40M | -2.76% | 229,766 | 5.00M |
| 226 | STRO | Sutro Biopharma, Inc. | 450.38M | 11.26% | 435,262 | 99.61M |
| 227 | OVID | Ovid Therapeutics Inc. | 446.07M | -0.42% | 2,021,713 | 7.12M |
| 228 | OCGN | Ocugen, Inc. | 440.08M | -2.99% | 4,346,112 | 4.47M |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.96M | -4.81% | 292,061 | - |
| 230 | CCCC | C4 Therapeutics, Inc. | 436.32M | -8.76% | 1,990,018 | 34.86M |
| 231 | AUTL | Autolus Therapeutics plc | 431.15M | -7.43% | 2,015,966 | 92.62M |
| 232 | EDIT | Editas Medicine, Inc. | 426.62M | -1.42% | 3,192,788 | 38.69M |
| 233 | CNXU | Conexeu Sciences Inc. | 425.80M | 0.06% | 154,224 | - |
| 234 | SGMT | Sagimet Biosciences Inc. | 423.62M | 1.03% | 662,289 | - |
| 235 | UPB | Upstream Bio, Inc. | 415.22M | 5.24% | 666,442 | 3.32M |
| 236 | FBRX | Forte Biosciences, Inc. | 414.55M | -6.66% | 321,857 | - |
| 237 | NGNE | Neurogene Inc. | 414.33M | 0.31% | 87,586 | 925.00K |
| 238 | VTVT | vTv Therapeutics Inc. | 409.02M | -0.12% | 22,693 | 36.84M |
| 239 | MNPR | Monopar Therapeutics Inc. | 405.54M | -1.18% | 72,825 | - |
| 240 | ADCT | ADC Therapeutics SA | 391.75M | -2.84% | 1,584,813 | 79.18M |
| 241 | CMPX | Compass Therapeutics, Inc. | 378.18M | 0.96% | 3,225,777 | 850.00K |
| 242 | XFOR | X4 Pharmaceuticals, Inc. | 374.45M | -1.73% | 385,686 | 9.01M |
| 243 | IPSC | Century Therapeutics, Inc. | 373.33M | -4.61% | 1,755,269 | 109.16M |
| 244 | ZURA | Zura Bio Limited | 366.24M | -5.85% | 669,369 | - |
| 245 | VNDA | Vanda Pharmaceuticals Inc. | 366.23M | -0.65% | 812,851 | 217.78M |
| 246 | STTK | Shattuck Labs, Inc. | 364.23M | -2.46% | 370,175 | 1.00M |
| 247 | PRLD | Prelude Therapeutics Incorporated | 362.99M | 4.57% | 363,091 | 16.72M |
| 248 | OABI | OmniAb, Inc. | 362.43M | -4.58% | 411,993 | 28.94M |
| 249 | BNTC | Benitec Biopharma Inc. | 357.29M | -1.69% | 88,615 | - |
| 250 | GLSI | Greenwich LifeSciences, Inc. | 356.53M | - | 115,221 | - |
| 251 | LXEO | Lexeo Therapeutics, Inc. | 353.35M | -0.22% | 628,520 | - |
| 252 | PBYI | Puma Biotechnology, Inc. | 346.63M | -2.44% | 226,054 | 227.18M |
| 253 | RGNX | REGENXBIO Inc. | 345.86M | 2.61% | 1,279,038 | 87.82M |
| 254 | ARTV | Artiva Biotherapeutics, Inc. | 338.66M | 1.46% | 491,064 | 251.00K |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 336.51M | -1.52% | 330,211 | - |
| 256 | LRMR | Larimar Therapeutics, Inc. | 334.03M | -3.03% | 1,851,697 | - |
| 257 | NAUT | Nautilus Biotechnology, Inc. | 327.86M | -3.73% | 360,497 | - |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 326.55M | -6.65% | 371,926 | 69.21M |
| 259 | IVVD | Invivyd, Inc. | 324.07M | -3.51% | 2,482,008 | 55.87M |
| 260 | ABEO | Abeona Therapeutics Inc. | 323.16M | -0.35% | 827,995 | 14.54M |
| 261 | PALI | Palisade Bio, Inc. | 323.13M | 3.76% | 3,278,395 | - |
| 262 | RCKT | Rocket Pharmaceuticals, Inc. | 318.85M | 1.04% | 2,840,732 | - |
| 263 | VSTM | Verastem, Inc. | 318.10M | -4.99% | 2,137,927 | 49.59M |
| 264 | NMRA | Neumora Therapeutics, Inc. | 317.88M | -0.57% | 647,288 | - |
| 265 | FENC | Fennec Pharmaceuticals Inc. | 317.50M | -8.42% | 237,759 | 51.00M |
| 266 | HUMA | Humacyte, Inc. | 310.83M | 0.72% | 5,489,141 | 2.02M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 304.44M | -2.08% | 186,012 | - |
| 268 | IFRX | InflaRx N.V. | 303.42M | -5.07% | 1,410,117 | 33.82K |
| 269 | SLN | Silence Therapeutics plc | 303.25M | 0.78% | 119,758 | 839.00K |
| 270 | IRD | Opus Genetics, Inc. | 299.89M | 5.26% | 915,488 | 11.98M |
| 271 | LCTX | Lineage Cell Therapeutics, Inc. | 299.16M | -0.83% | 801,173 | 14.78M |
| 272 | IMRX | Immuneering Corporation | 294.37M | 6.31% | 1,936,895 | - |
| 273 | LYEL | Lyell Immunopharma, Inc. | 293.31M | -15.58% | 412,786 | 31.00K |
| 274 | BCYC | Bicycle Therapeutics plc | 293.21M | -2.33% | 413,739 | 63.50M |
| 275 | SRZN | Surrozen, Inc. | 286.37M | 6.57% | 78,357 | 7.49M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 284.61M | -1.76% | 845,808 | 1.00 |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 281.19M | -5.82% | 1,153,061 | 26.87M |
| 278 | ARMP | Armata Pharmaceuticals, Inc. | 274.85M | -5.43% | 31,377 | 5.20M |
| 279 | NAGE | Niagen Bioscience, Inc. | 274.55M | -2.82% | 629,402 | 130.42M |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 269.79M | -1.13% | 1,059,234 | - |
| 281 | MGNX | MacroGenics, Inc. | 266.95M | 3.70% | 620,920 | 157.08M |
| 282 | FATE | Fate Therapeutics, Inc. | 258.76M | -13.62% | 7,262,760 | 6.32M |
| 283 | YDES | YD Bio Limited | 253.85M | 13.17% | 54,122 | 510.36K |
| 284 | INDP | Indaptus Therapeutics, Inc. | 250.27M | 2.79% | 97,925 | - |
| 285 | CDXS | Codexis, Inc. | 247.24M | 1.12% | 677,970 | 78.09M |
| 286 | NVCT | Nuvectis Pharma, Inc. | 246.95M | -2.10% | 68,785 | - |
| 287 | AVXL | Anavex Life Sciences Corp. | 245.12M | -5.03% | 1,054,028 | - |
| 288 | TARA | Protara Therapeutics, Inc. | 237.18M | -2.76% | 515,601 | - |
| 289 | TRDA | Entrada Therapeutics, Inc. | 237.10M | -0.90% | 238,887 | 5.74M |
| 290 | ACIU | AC Immune SA | 237.09M | -1.24% | 250,536 | 4.62M |
| 291 | SABS | SAB Biotherapeutics, Inc. | 236.13M | -3.45% | 326,709 | 114.70K |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 233.73M | -3.02% | 26,944 | 18.47M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 231.14M | -1.28% | 240,550 | 32.72M |
| 294 | ELTX | Elicio Therapeutics, Inc. | 230.50M | 9.05% | 150,442 | - |
| 295 | ADAG | Adagene Inc. | 228.61M | 2.06% | 47,688 | 7.67M |
| 296 | CLLS | Cellectis S.A. | 227.37M | -8.58% | 101,180 | 75.11M |
| 297 | CHRS | Coherus Oncology, Inc. | 226.75M | -3.29% | 1,034,359 | 46.88M |
| 298 | ALXO | ALX Oncology Holdings Inc. | 224.72M | -6.18% | 707,721 | - |
| 299 | LENZ | LENZ Therapeutics, Inc. | 219.79M | -1.68% | 443,382 | 20.99M |
| 300 | NERV | Minerva Neurosciences, Inc. | 218.04M | -1.47% | 108,607 | - |
| 301 | VYGR | Voyager Therapeutics, Inc. | 217.52M | 0.28% | 420,702 | 36.49M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 216.02M | -0.65% | 468,827 | 54.71M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 216.01M | 4.52% | 48,446 | 3.93M |
| 304 | HELP | Cybin Inc. | 215.15M | -5.49% | 516,990 | - |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 215.01M | 4.07% | 168,245 | 7.15M |
| 306 | FULC | Fulcrum Therapeutics, Inc. | 214.56M | 2.55% | 5,596,130 | 80.00M |
| 307 | FHTX | Foghorn Therapeutics Inc. | 213.72M | 0.28% | 144,264 | 28.22M |
| 308 | RNA | Atrium Therapeutics, Inc. | 208.18M | -0.65% | 150,001 | 36.68M |
| 309 | KROS | Keros Therapeutics, Inc. | 207.81M | -0.47% | 190,322 | 33.18M |
| 310 | QTTB | Q32 Bio Inc. | 206.70M | -3.56% | 537,651 | 53.74M |
| 311 | CGEN | Compugen Ltd. | 206.19M | -3.54% | 807,844 | 72.66M |
| 312 | ENLV | Enlivex Ltd. | 204.89M | 0.01% | 489,603 | - |
| 313 | NGEN | NervGen Pharma Corp. | 202.85M | -4.50% | 1,151,483 | - |
| 314 | NBP | NovaBridge Biosciences | 202.38M | 2.34% | 550,314 | - |
| 315 | KPTI | Karyopharm Therapeutics Inc. | 201.38M | -3.25% | 499,682 | 151.12M |
| 316 | CRBU | Caribou Biosciences, Inc. | 198.36M | -13.79% | 2,121,136 | 11.20M |
| 317 | ALEC | Alector, Inc. | 197.07M | -8.97% | 1,691,027 | 18.42M |
| 318 | EQ | Equillium, Inc. | 196.63M | 11.47% | 3,698,493 | 4.39M |
| 319 | NKTX | Nkarta, Inc. | 194.60M | -6.53% | 479,250 | - |
| 320 | IMUX | Immunic, Inc. | 193.02M | -3.21% | 241,356 | - |
| 321 | UNCY | Unicycive Therapeutics, Inc. | 192.24M | -0.41% | 512,739 | - |
| 322 | CNTX | Context Therapeutics Inc. | 188.35M | -15.29% | 881,617 | - |
| 323 | RNAC | Cartesian Therapeutics, Inc. | 184.08M | -2.26% | 162,144 | 1.78M |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 181.73M | -2.73% | 360,529 | 17.56M |
| 325 | TTRX | Turn Therapeutics Inc. | 179.32M | -6.23% | 90,444 | - |
| 326 | MDWD | MediWound Ltd. | 176.46M | -0.22% | 162,766 | 14.48M |
| 327 | MIST | Milestone Pharmaceuticals Inc. | 174.14M | -3.03% | 812,488 | 1.78M |
| 328 | IPHA | Innate Pharma S.A. | 171.10M | -3.30% | 19,624 | 10.57M |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 170.52M | -0.53% | 5,405,300 | 225.00K |
| 330 | OKUR | OnKure Therapeutics, Inc. | 169.66M | -0.47% | 325,678 | - |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 165.40M | -3.38% | 299,891 | - |
| 332 | SPRO | Spero Therapeutics, Inc. | 162.12M | -1.06% | 753,311 | 61.19M |
| 333 | KRRO | Korro Bio, Inc. | 159.80M | 0.73% | 131,200 | 3.84M |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 157.92M | -1.51% | 834,770 | 76.38M |
| 335 | DTIL | Precision BioSciences, Inc. | 155.85M | -4.43% | 234,408 | 45.07M |
| 336 | MENS | Jyong Biotech Ltd. | 155.15M | -3.24% | 53,212 | - |
| 337 | PRQR | ProQR Therapeutics N.V. | 154.88M | - | 660,985 | 15.73M |
| 338 | GALT | Galectin Therapeutics Inc. | 154.11M | -3.31% | 225,991 | - |
| 339 | TLSA | Tiziana Life Sciences Ltd | 152.58M | -13.24% | 643,521 | - |
| 340 | ANTX | AN2 Therapeutics, Inc. | 151.18M | 3.19% | 214,455 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 149.38M | 1.39% | 359,914 | 2.00M |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 146.59M | -12.34% | 4,562,381 | 2.29M |
| 343 | MOLN | Molecular Partners AG | 143.12M | 2.81% | 14,592 | 856.30K |
| 344 | CNTB | Connect Biopharma Holdings Limited | 140.41M | 3.72% | 442,514 | 233.00K |
| 345 | CNTN | Canton Strategic Holdings, Inc. | 138.81M | 3.38% | 630,953 | - |
| 346 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 136.74M | -2.12% | 522,926 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 135.01M | -2.75% | 487,920 | - |
| 348 | AGEN | Agenus Inc. | 133.75M | -4.73% | 466,940 | 123.87M |
| 349 | GNLX | Genelux Corporation | 133.23M | 1.69% | 307,031 | 8.00K |
| 350 | SPRB | Spruce Biosciences, Inc. | 132.55M | -0.51% | 64,308 | 697.00K |
| 351 | ACOG | Alpha Cognition Inc. | 132.39M | -1.21% | 4,900 | 10.83M |
| 352 | CGTX | Cognition Therapeutics, Inc. | 126.88M | 5.19% | 2,199,020 | - |
| 353 | KZIA | Kazia Therapeutics Limited | 125.12M | -7.12% | 451,766 | 1.27M |
| 354 | GUTS | Fractyl Health, Inc. | 120.57M | -3.76% | 1,239,277 | 3.00K |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 120.33M | -3.67% | 817,193 | 70.00M |
| 356 | PLYX | Polaryx Therapeutics, Inc. | 119.31M | -4.55% | 128,870 | - |
| 357 | ALPS | Alps Group Inc | 118.13M | 2.57% | 127,411 | 3.74M |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 112.20M | 13.41% | 2,018,863 | - |
| 359 | ENGN | enGene Therapeutics Inc. | 111.87M | -4.02% | 812,204 | - |
| 360 | VANI | Vivani Medical, Inc. | 110.38M | -1.54% | 117,342 | - |
| 361 | NTHI | NeOnc Technologies Holdings, Inc. | 110.13M | -3.71% | 49,267 | 39.99K |
| 362 | COYA | Coya Therapeutics, Inc. | 108.84M | -1.90% | 114,637 | 7.94M |
| 363 | KLRS | Kalaris Therapeutics, Inc. | 108.52M | 1.51% | 45,562 | - |
| 364 | PYXS | Pyxis Oncology, Inc. | 107.70M | -0.58% | 179,172 | 13.86M |
| 365 | CBUS | Cibus, Inc. | 105.27M | -0.72% | 182,298 | 3.64M |
| 366 | SEER | Seer, Inc. | 104.94M | -0.53% | 56,603 | 16.58M |
| 367 | ONCY | Oncolytics Biotech Inc. | 102.19M | -5.13% | 1,558,688 | - |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 100.84M | 1.38% | 24,840 | 37.16M |
| 369 | PEPG | PepGen Inc. | 98.22M | -2.07% | 463,230 | - |
| 370 | OTLK | Outlook Therapeutics, Inc. | 97.88M | -0.47% | 10,341,337 | 333.14K |
| 371 | CRDF | Cardiff Oncology, Inc. | 95.72M | -7.28% | 2,465,548 | 525.00K |
| 372 | RNTX | Rein Therapeutics Inc. | 94.90M | -0.97% | 407,282 | - |
| 373 | BMEA | Biomea Fusion, Inc. | 93.99M | -5.11% | 1,298,162 | - |
| 374 | INO | Inovio Pharmaceuticals, Inc. | 93.41M | -5.79% | 1,760,600 | 65.34K |
| 375 | ICCC | ImmuCell Corporation | 90.92M | 2.66% | 15,761 | 29.93M |
| 376 | PYPD | PolyPid Ltd. | 90.50M | -3.08% | 202,776 | - |
| 377 | PTHS | Pelthos Therapeutics Inc. | 89.95M | -0.46% | 6,877 | 27.70M |
| 378 | HYFT | MindWalk Holdings Corp. | 89.40M | -8.63% | 561,357 | 20.70M |
| 379 | CUE | Cue Biopharma, Inc. | 87.60M | -5.97% | 67,731 | 32.73M |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 87.35M | 2.03% | 701,853 | 3.17M |
| 381 | OKYO | OKYO Pharma Limited | 87.12M | -2.35% | 31,246 | - |
| 382 | MAIA | MAIA Biotechnology, Inc. | 86.95M | 5.93% | 2,177,816 | - |
| 383 | FBIO | Fortress Biotech, Inc. | 86.70M | -1.51% | 282,003 | 66.16M |
| 384 | PMN | ProMIS Neurosciences, Inc. | 86.54M | -4.93% | 38,025 | - |
| 385 | RLYB | Rallybio Corporation | 85.01M | -0.99% | 54,352 | 858.00K |
| 386 | HRTX | Heron Therapeutics, Inc. | 84.57M | -0.71% | 10,794,725 | 150.71M |
| 387 | ANIX | Anixa Biosciences, Inc. | 84.49M | -1.18% | 89,622 | - |
| 388 | AARD | Aardvark Therapeutics, Inc. | 83.12M | -4.03% | 149,390 | - |
| 389 | ACET | Adicet Bio, Inc. | 82.22M | -3.45% | 113,709 | - |
| 390 | ATRA | Atara Biotherapeutics, Inc. | 81.97M | -2.73% | 104,241 | 23.14M |
| 391 | NRXS | NeurAxis, Inc. | 81.34M | 0.86% | 186,001 | 4.28M |
| 392 | LONA | LeonaBio, Inc. | 81.07M | -4.32% | 37,523 | - |
| 393 | EXOZ | eXoZymes, Inc. | 80.21M | -0.42% | 1,878 | -700.00 |
| 394 | OSTX | OS Therapies Incorporated | 80.17M | -1.64% | 624,483 | - |
| 395 | CSBR | Champions Oncology, Inc. | 78.74M | -0.96% | 12,782 | 57.95M |
| 396 | ANVS | Annovis Bio, Inc. | 78.70M | -0.54% | 693,930 | - |
| 397 | LIXT | Lixte Biotechnology Holdings, Inc. | 77.84M | -4.83% | 244,296 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 76.35M | -2.19% | 367,729 | - |
| 399 | XBIT | XBiotech Inc. | 72.56M | -1.24% | 45,138 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 72.45M | 0.86% | 1,589,173 | - |
| 401 | BYSI | BeyondSpring Inc. | 72.37M | 3.53% | 13,173 | 1.88M |
| 402 | ATHE | Alterity Therapeutics Limited | 70.35M | -0.25% | 15,446 | 4.43M |
| 403 | MCRB | Seres Therapeutics, Inc. | 69.43M | -2.18% | 49,839 | 1.15M |
| 404 | IBIO | iBio, Inc. | 66.50M | 4.55% | 724,152 | 300.00K |
| 405 | FLNA | Filana Therapeutics, Inc. | 65.70M | -5.56% | 291,871 | - |
| 406 | MNOV | MediciNova, Inc. | 64.97M | -1.49% | 25,458 | 596.64K |
| 407 | CING | Cingulate Inc. | 64.79M | 21.09% | 1,106,473 | - |
| 408 | ACRV | Acrivon Therapeutics, Inc. | 64.63M | -3.82% | 296,429 | - |
| 409 | INKT | MiNK Therapeutics, Inc. | 63.57M | 6.69% | 37,504 | - |
| 410 | TCRX | TScan Therapeutics, Inc. | 63.52M | -0.82% | 437,351 | 9.14M |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 61.86M | -1.69% | 269,896 | - |
| 412 | IMA | ImageneBio, Inc. | 61.47M | - | 6,380 | 800.00K |
| 413 | EDSA | Edesa Biotech, Inc. | 60.96M | 0.44% | 148,334 | - |
| 414 | PDSB | PDS Biotechnology Corporation | 60.28M | -6.90% | 690,480 | - |
| 415 | ENTX | Entera Bio Ltd. | 60.05M | -2.40% | 44,124 | 42.00K |
| 416 | IBO | Impact BioMedical Inc. | 58.43M | 4.03% | 50,808 | 39.00K |
| 417 | TIL | Instil Bio, Inc. | 55.82M | 1.48% | 14,748 | - |
| 418 | DWTX | Dogwood Therapeutics, Inc. | 53.78M | -3.59% | 64,916 | - |
| 419 | IMMP | Immutep Limited | 53.68M | -2.24% | 698,039 | 5.28M |
| 420 | MREO | Mereo BioPharma Group plc | 53.34M | -1.53% | 6,807,264 | 500.00K |
| 421 | HYPD | Hyperion DeFi, Inc. | 51.28M | -2.43% | 483,705 | 1.04M |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 50.45M | 0.75% | 151,758 | 22.33M |
| 423 | GNTA | Genenta Science S.p.A. | 49.78M | -4.09% | 960,739 | - |
| 424 | RADX | Radiopharm Theranostics Limited | 49.67M | -1.32% | 32,947 | 10.86M |
| 425 | ATYR | aTyr Pharma, Inc. | 49.04M | -3.83% | 1,721,327 | 190.00K |
| 426 | XLO | Xilio Therapeutics, Inc. | 48.88M | -0.37% | 9,613 | 53.48M |
| 427 | ESLA | Estrella Immunopharma, Inc. | 45.19M | -2.78% | 44,859 | - |
| 428 | GOSS | Gossamer Bio, Inc. | 44.19M | -5.94% | 12,219,697 | 55.54M |
| 429 | ACTU | Actuate Therapeutics, Inc. | 44.02M | -2.13% | 82,406 | - |
| 430 | NTRB | Nutriband Inc. | 42.67M | -1.13% | 7,111 | 2.04M |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 42.29M | -0.81% | 73,366 | - |
| 432 | KALA | KALA BIO, Inc. | 41.64M | -6.28% | 57,730 | - |
| 433 | RNXT | RenovoRx, Inc. | 40.80M | -0.54% | 331,950 | 1.49M |
| 434 | ATOS | Atossa Therapeutics, Inc. | 40.47M | -3.09% | 44,631 | - |
| 435 | GRDX | GridAI Technologies Corp. | 39.45M | -8.35% | 95,251 | - |
| 436 | LTRN | Lantern Pharma Inc. | 38.11M | -9.09% | 190,042 | - |
| 437 | TVGN | Tevogen Bio Holdings Inc. | 37.94M | 6.97% | 15,172 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 37.91M | -2.00% | 185,182 | - |
| 439 | PSTV | Plus Therapeutics, Inc. | 37.19M | -0.91% | 105,304 | 5.21M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 36.16M | -4.92% | 230,520 | 90.00K |
| 441 | VERU | Veru Inc. | 36.11M | -4.26% | 70,105 | 16.89M |
| 442 | INMB | INmune Bio Inc. | 35.09M | -7.04% | 379,435 | 50.00K |
| 443 | NNVC | NanoViricides, Inc. | 34.40M | -5.03% | 407,837 | - |
| 444 | QNTM | Quantum BioPharma Ltd. | 32.85M | -4.50% | 353,951 | - |
| 445 | ABVC | ABVC BioPharma, Inc. | 32.35M | 2.40% | 129,559 | 797.92K |
| 446 | BOLD | Boundless Bio, Inc. | 32.28M | 0.70% | 134,376 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 31.81M | -2.10% | 51,165 | 4.71M |
| 448 | LSTA | Lisata Therapeutics, Inc. | 31.43M | - | 49,472 | 170.00K |
| 449 | DARE | Daré Bioscience, Inc. | 30.71M | -4.21% | 218,895 | 1.16M |
| 450 | APLM | Apollomics, Inc. | 30.57M | -1.97% | 8,478 | 8.84M |
| 451 | SNTI | Senti Biosciences Holdings, Inc. | 30.38M | -0.86% | 142,752 | 38.00K |
| 452 | IGC | IGC Pharma, Inc. | 29.64M | 3.45% | 1,576,611 | 1.11M |
| 453 | LITS | Lite Strategy, Inc. | 29.57M | 6.50% | 661,658 | - |
| 454 | CELU | Celularity Inc. | 29.52M | -3.77% | 160,728 | 26.55M |
| 455 | EVAX | Evaxion A/S | 29.52M | -5.60% | 18,244 | 7.53M |
| 456 | BRNS | Barinthus Biotherapeutics plc | 28.63M | 6.18% | 3,990 | 14.97M |
| 457 | CRVO | CervoMed Inc. | 27.68M | -0.33% | 43,302 | 2.09M |
| 458 | TVRD | Tvardi Therapeutics, Inc. | 27.67M | -6.94% | 56,770 | - |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 27.59M | -2.45% | 89,771 | - |
| 460 | KYNB | Kyntra Bio, Inc. | 27.53M | -0.59% | 5,829 | 7.44M |
| 461 | SKYE | Skye Bioscience, Inc. | 27.05M | 7.89% | 168,553 | - |
| 462 | SER | Serina Therapeutics, Inc. | 26.67M | 1.70% | 24,299 | 130.00K |
| 463 | DYAI | Dyadic International, Inc. | 25.54M | 1.64% | 142,528 | 3.81M |
| 464 | PLUR | Pluri Inc. | 25.46M | -0.21% | 3,023 | 1.08M |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 25.40M | -3.89% | 76,461 | -13.27K |
| 466 | PLRZ | Polyrizon Ltd. | 25.20M | -4.47% | 18,322 | - |
| 467 | PTN | Palatin Technologies, Inc. | 24.87M | -2.88% | 10,899 | 12.88M |
| 468 | ALLR | Allarity Therapeutics, Inc. | 24.43M | -6.51% | 134,239 | 345.00K |
| 469 | MRKR | Marker Therapeutics, Inc. | 24.18M | 2.11% | 23,304 | 3.55M |
| 470 | BCTX | BriaCell Therapeutics Corp. | 23.65M | 1.22% | 142,934 | - |
| 471 | LGVN | Longeveron Inc. | 23.42M | 5.26% | 326,463 | 1.22M |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 22.19M | -3.43% | 564,291 | 789.00K |
| 473 | VYNE | VYNE Therapeutics Inc. | 21.99M | -2.38% | 146,263 | 454.00K |
| 474 | TRAW | Traws Pharma, Inc. | 21.97M | 2.11% | 216,217 | 2.73M |
| 475 | CVM | CEL-SCI Corporation | 21.45M | -0.67% | 140,849 | - |
| 476 | KTTA | Pasithea Therapeutics Corp. | 21.33M | -1.05% | 368,671 | - |
| 477 | SNSE | Sensei Biotherapeutics, Inc. | 21.06M | -2.49% | 44,499 | - |
| 478 | CLRB | Cellectar Biosciences, Inc. | 20.78M | -5.11% | 241,655 | - |
| 479 | HOWL | Werewolf Therapeutics, Inc. | 20.53M | -1.77% | 376,217 | 1.14M |
| 480 | XCUR | Exicure, Inc. | 20.14M | 1.61% | 2,630 | 500.00K |
| 481 | CRIS | Curis, Inc. | 19.99M | -0.50% | 157,690 | 7.06M |
| 482 | AEON | AEON Biopharma, Inc. | 19.24M | -2.49% | 9,477 | - |
| 483 | PASG | Passage Bio, Inc. | 19.15M | 1.27% | 34,964 | - |
| 484 | TPST | Tempest Therapeutics, Inc. | 18.22M | -3.05% | 114,349 | - |
| 485 | LPCN | Lipocine Inc. | 17.58M | -2.67% | 59,882 | 2.00M |
| 486 | AKTX | Akari Therapeutics, Plc | 17.15M | 2.43% | 59,596 | - |
| 487 | NCEL | NewcelX Ltd. | 17.01M | -4.82% | 9,510 | - |
| 488 | MLEC | Moolec Science SA | 16.85M | 18.59% | 147,759 | 7.83M |
| 489 | QNCX | Quince Therapeutics, Inc. | 16.79M | -1.90% | 1,104,470 | - |
| 490 | HIND | Vyome Holdings, Inc. | 15.93M | -1.30% | 48,532 | 152.72K |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 15.93M | -3.81% | 295,806 | 5.61M |
| 492 | GTBP | GT Biopharma, Inc. | 15.84M | -5.97% | 919,579 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 15.36M | 3.09% | 59,652 | 368.00K |
| 494 | INAB | IN8bio, Inc. | 15.16M | -1.28% | 98,178 | - |
| 495 | JSPR | Jasper Therapeutics, Inc. | 14.90M | -3.45% | 1,639,335 | - |
| 496 | OSRH | OSR Holdings, Inc. | 14.77M | 3.42% | 1,852,509 | 2.63M |
| 497 | BLRX | BioLineRx Ltd. | 14.62M | -3.24% | 19,937 | 1.40M |
| 498 | COCP | Cocrystal Pharma, Inc. | 14.61M | 0.95% | 73,254 | 225.00K |
| 499 | GDTC | CytoMed Therapeutics Limited | 13.96M | 3.51% | 1,346 | 669.28K |
| 500 | MTVA | MetaVia Inc. | 13.84M | -1.11% | 315,381 | - |